Abstract
The aim of this study was to test the hypothesis that in the United States substantial practice variation exists in triple therapy prescribing practices, unrelated to measured patient factors. Recent data have shown that the risk of bleeding on dual antiplatelet therapy and oral anticoagulation ("triple therapy") is high, although the optimal strategy for patients with atrial fibrillation and coronary artery disease remains unclear. Using the PINNACLE (National Practice Innovation and Clinical Excellence) registry, we identified 79,875 unique patients with both atrial fibrillation/atrial flutter and myocardial infarction and/or coronary stenting within 12 months. Using triple therapy as a binary outcome variable, we created a mixed-effects logistic regression model with patient factors as fixed effects and practice site as a random effect. Patient factors included age, sex, diabetes, congestive heart failure, hypertension, peripheral arterial disease, prior stroke or transient ischemic attack, history of systemic embolization, and dyslipidemia. The model was assessed with a median odds ratio to assess practice variation after adjustment for patient factors. After adjustment for patient factors, significant practice variation wa...Continue Reading
References
Feb 1, 1996·Heart·G Y LipD G Beevers
Jun 13, 2001·JAMA : the Journal of the American Medical Association·B F GageM J Radford
Dec 24, 2004·American Journal of Epidemiology·Klaus Larsen, Juan Merlo
May 5, 2005·JAMA : the Journal of the American Medical Association·Ioannis IakovouAntonio Colombo
Jan 25, 2008·American Heart Journal·Tracy Y WangRichard C Becker
Jul 17, 2009·Heart·Albert SchömigMelchior Seyfarth
Sep 19, 2009·Chest·Gregory Y H LipHarry J G M Crijns
Mar 20, 2010·Chest·Ron PistersGregory Y H Lip
Jul 14, 2010·Journal of the American College of Cardiology·Paul S ChanJohn A Spertus
Jul 27, 2010·Congenital Heart Disease·Rahul H RathodJames E Lock
Sep 29, 2011·Journal of Interventional Cardiology·Andrea RubboliGregory Y H Lip
Jul 20, 2012·Journal of the American College of Cardiology·Hani JneidJames Patrick Zidar
Sep 22, 2012·JACC. Cardiovascular Interventions·Sunil V RaoEric D Peterson
Jan 18, 2013·The Annals of Pharmacotherapy·Mukaila A RajiJames S Goodwin
Feb 19, 2013·Lancet·Willem J M DewildeUNKNOWN WOEST study investigators
Apr 6, 2013·Journal of the American College of Cardiology·Jeffrey L AndersonSamuel Wann
Jul 3, 2013·JAMA Internal Medicine·Salim S ViraniLaura A Petersen
Oct 22, 2013·Cardiology Journal·Birga MaierSteffen Behrens
Nov 5, 2013·Journal of the American College of Cardiology·Thomas M MaddoxPamela N Peterson
Jan 28, 2014·Thrombosis Research·Marja K PuurunenK E Juhani Airaksinen
Nov 18, 2014·The New England Journal of Medicine·Laura MauriUNKNOWN DAPT Study Investigators
Feb 11, 2015·Journal of the American College of Cardiology·Davide Capodanno, Gregory Y H Lip
Feb 11, 2015·Journal of the American College of Cardiology·Willem J M DewildeJurriën M ten Berg
Apr 25, 2015·Journal of the American College of Cardiology·Katrin A FiedlerNikolaus Sarafoff
Jun 3, 2015·Circulation·Sorin J Brener
Jun 3, 2015·Circulation·Richard C Becker, Tarek Helmy
Citations
Sep 21, 2018·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Lindsay J MayDavid N Rosenthal
Aug 14, 2020·Journal of Cardiovascular Pharmacology and Therapeutics·Robert N KerleyRonan Curtin
Apr 21, 2021·Circulation. Cardiovascular Interventions·Matthew W SherwoodEric D Peterson
Aug 19, 2021·Circulation. Cardiovascular Quality and Outcomes·Daniel M BlumenthalJason H Wasfy